{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:57:56Z","timestamp":1769277476789,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.exppara.2014.04.013","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T17:15:22Z","timestamp":1398532522000},"page":"5-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB\/c mice"],"prefix":"10.1016","volume":"143","author":[{"given":"S.A.","family":"Moosavian Kalat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bavarsad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Khashayarmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Neghabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2014.04.013_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-3659(01)00549-1","article-title":"Targeting to macrophages: role of physicochemical properties of particulate carriers \u2013 liposomes and microspheres \u2013 on the phagocytosis by macrophages","volume":"79","author":"Ahsan","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.exppara.2014.04.013_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0169-409X(88)90007-5","article-title":"Macrophages as targets for delivery of liposome-encapsulated antimicrobial agents","volume":"2","author":"Alving","year":"1988","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.exppara.2014.04.013_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2014.04.013_b0020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1995.53.648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran","volume":"53","author":"Asilian","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2014.04.013_b0025","article-title":"Treatment of acute cutaneous leishmaniasis with intralesional emetine using a new injection technique","volume":"1","author":"Asilian","year":"2010","journal-title":"J. Skin. Leishmania"},{"key":"10.1016\/j.exppara.2014.04.013_b0030","first-page":"252","article-title":"Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation","volume":"7","author":"Bhatia","year":"2004","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.exppara.2014.04.013_b0035","series-title":"Methods for Studying Precutaneous Absorption","author":"Brain","year":"2002"},{"key":"10.1016\/j.exppara.2014.04.013_b0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1179\/000349803235001840","article-title":"Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis","volume":"97","author":"Cauchetier","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.exppara.2014.04.013_b0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00436-002-0706-4","article-title":"A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein","volume":"89","author":"Chan","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2014.04.013_b0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","article-title":"Monitoring drug resistance in leishmaniasis","volume":"6","author":"Croft","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2014.04.013_b0055","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis \u2013 current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2014.04.013_b0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","article-title":"Chemotherapy of leishmaniasis","volume":"8","author":"Croft","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.exppara.2014.04.013_b0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4269\/ajtmh.2008.78.745","article-title":"Antileishmanial activity of azitahromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi","volume":"78","author":"de Oliveira-Silva","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2014.04.013_b0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejps.2008.05.002","article-title":"Liposomes and skin: from drug delivery to model membranes","volume":"34","author":"El Maghraby","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.exppara.2014.04.013_b0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1081\/DDC-120030423","article-title":"In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis","volume":"30","author":"Ferreira","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.exppara.2014.04.013_b0085","series-title":"Biphasic Multilamellar Lipid Vesicles","author":"Foldvari","year":"1998"},{"key":"10.1016\/j.exppara.2014.04.013_b0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/02652049009040470","article-title":"Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies","volume":"7","author":"Foldvari","year":"1990","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.exppara.2014.04.013_b0095","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1590\/S0100-879X2000000700016","article-title":"Novel methods for the encapsulation of meglumine antimoniate into liposomes","volume":"33","author":"Frezard","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.exppara.2014.04.013_b0090","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Frezard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.exppara.2014.04.013_b0100","first-page":"75","article-title":"Liposomes from vegetable phosphatidylcholin: their production and effects on the skin","volume":"109","author":"Ghyczy","year":"1994","journal-title":"Cosmet. Toilter."},{"key":"10.1016\/j.exppara.2014.04.013_b0110","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2006.04.062","article-title":"Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice","volume":"24","author":"Jaafari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2014.04.013_b0105","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/AAC.01319-08","article-title":"Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB\/c mice","volume":"53","author":"Jaafari","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2014.04.013_b0115","first-page":"513","article-title":"Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis","volume":"17","author":"Kashani","year":"2007","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.exppara.2014.04.013_b0125","first-page":"1","article-title":"Comparison of efficacy of intralesional injection of meglumine antimoniate once-weekly with twice-weekly in the treatment of anthroponotic cutaneous leishmaniasis in Mashhad: a randomized clinical trial","volume":"2","author":"Khamesipour","year":"2001","journal-title":"Dermat. Cosmet."},{"key":"10.1016\/j.exppara.2014.04.013_b0120","first-page":"155","article-title":"Comparison of the efficacy of weekly vs. twice a week intralesional injections of meglumine antimoniate in the treatment of anthroponotic cutaneous leishmaniasis: a randomized clinical trial","volume":"1","author":"Khamesipour","year":"2010","journal-title":"Dermat. Cosmet."},{"key":"10.1016\/j.exppara.2014.04.013_b0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2005.07.005","article-title":"Assessment of drug permeability distributions in two different model skins","volume":"303","author":"Khan","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2014.04.013_b0140","first-page":"79","article-title":"A new automatized fluorometric assay for anti-Leishmania drug screening","volume":"47","author":"Le Pape","year":"2002","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.exppara.2014.04.013_b0135","first-page":"301","article-title":"A new fluorometric method for anti-Leishmania drug screening on axenic amastigotes","volume":"48","author":"Le Pape","year":"2003","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.exppara.2014.04.013_b0145","first-page":"1455","article-title":"Cutaneous leishmaniasis: recognition and treatment","volume":"69","author":"Markle","year":"2004","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.exppara.2014.04.013_b0150","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00436-006-0394-6","article-title":"Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis","volume":"100","author":"Mussi","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2014.04.013_b0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/156720105774370177","article-title":"Targeted drug delivery to macrophages in parasitic infections","volume":"2","author":"Owais","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.exppara.2014.04.013_b0165","series-title":"Liposomes and Skin Permeability Barrier","author":"Patel","year":"1993"},{"key":"10.1016\/j.exppara.2014.04.013_b0170","doi-asserted-by":"crossref","unstructured":"Patel, S.S., Patel, M.S., Salampure, S., Vishwanath, B., Patel, N.M., Development and evaluation of liposomes for topical delivery of Tacrolimus (Fk-506), 2010.","DOI":"10.3329\/jsr.v2i3.3258"},{"key":"10.1016\/j.exppara.2014.04.013_b0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11095-005-9261-x","article-title":"Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy","volume":"23","author":"Pierre","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.exppara.2014.04.013_b0180","series-title":"Bioassay Techniques for Drug Development","author":"Rahman","year":"2001"},{"key":"10.1016\/j.exppara.2014.04.013_b0185","first-page":"85","article-title":"Comparison of topical paromomycin sulfate (twice\/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major","volume":"15","author":"Shazad","year":"2005","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.exppara.2014.04.013_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-3659(98)00144-8","article-title":"In vivo human skin permeability enhancement by oleic acid: a laser Doppler velocimetry study","volume":"58","author":"Tanojo","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.exppara.2014.04.013_b0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jac\/dkh281","article-title":"Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine","volume":"54","author":"Tempone","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2014.04.013_b0200","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijantimicag.2011.05.012","article-title":"Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages","volume":"38","author":"Treiger Borborema","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2014.04.013_b0155","unstructured":"World Health Organization., 2010. Control of the Leishmaniases."},{"key":"10.1016\/j.exppara.2014.04.013_b0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489414001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489414001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T12:01:05Z","timestamp":1597752065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489414001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":41,"alternative-id":["S0014489414001118"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2014.04.013","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2014.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}